Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Daniel Cravo, Sartrouville FR
Daniel Cravo, Sartrouville FR
| Patent application number | Description | Published |
|---|---|---|
| 20100158999 | COMBINATION OF TRIAZINE DERIVATIVES AND HMG-COA REDUCTASE INHIBITORS - The present patent application relates to combinations of a triazine derivative with an HMG-CoA reductase inhibitor. | 06-24-2010 |
| 20100159005 | COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS - The present patent application relates to combinations of triazine derivatives and of PPARα agonists. | 06-24-2010 |
| 20100168115 | USE OF TRIAZINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT HAVING A CICATRISING OR ANGIOGENIC EFFECT - The present patent application relates to the use of triazine derivatives as cicatrising or angiogenic agents, wherein the triazine is a molecule of formula (I). | 07-01-2010 |
| 20100216794 | PYRIDINE DERIVATIVES USEFUL AS GLUCOKINASE ACTIVATORS - Novel heterocyclic compounds of the formula I | 08-26-2010 |
| 20100233255 | COMBINATION OF TRAZINE DERIVATIVES AND INSULIN SECRETION STIMULATORS - The present patent application relates to novel combinations of a triazine derivative and of an insulin secretion stimulator. | 09-16-2010 |
| 20100285117 | COMBINATION OF TRIAZINE DERIVATIVES AND INSULIN SENSITISERS - The present invention relates to combinations of triazine derivatives and of insulin sensitisers. | 11-11-2010 |
| 20110034505 | THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS - The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined in claim | 02-10-2011 |
| 20110060001 | THIENOPYRIDONE DERIVATIVES AS AMP- ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS - The present invention relates to compounds of formula (I) wherein R | 03-10-2011 |
| 20110124860 | PROCESS FOR THE SYNTHESIS OF 3,6-DIHYDRO-1,3,5-TRIAZINE DERIVATIVES - A new process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives for the treatment of disorders associated with insulin-resistance syndrome. | 05-26-2011 |
| 20110130404 | QUINOXALINEDIONE DERIVATIVES - The present invention relates to compounds of formula (I) | 06-02-2011 |
